Acute renal failure occurring in scleroderma treated with cyclosporin a: A report of three cases

Rheumatology

Volumn 33, Issue 1, 1994, Pages 90-92

  Denton, C P ^a   Sweny, P ^a   Abdulla, A ^a   Black, C M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Connective tissue disease; Nephrotoxicity; Systemic sclerosis

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SCLERODERMA;

ADULT; CASE REPORT; CYCLOSPORINE; FEMALE; HUMAN; INCIDENCE; KIDNEY FAILURE, ACUTE; MIDDLE AGE; SCLERODERMA, SYSTEMIC;

EID: 0028081921     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/33.1.90     Document Type: Article

References (22)

1. Claman HN, Giorno RC, Seibold JR. Endothelial and fibroblastic activation in scleroderma. Arthritis Rheum 1991;34:1495-1501.
2. Korn JH. Immunological aspects of scleroderma. Curr Opin Rheumatol 1991;3:947-52.
3. Black CM, Stephens CO. Systemic sclerosis (scleroderma) and related disorders. In: Oxford textbook of rheumatology. Oxford: Oxford University Press; 1993.
4. Kahan BD. Cyclosporine. New Engl J Med 1989;321: 1725-38.
5. Silman AJ. Scleroderma and survival. Ann Rheum Dis 1991;50:267-9.
6. Yoccum DE and Wilder RL. Cyclosporin A in systemic sclerosis. Am Med J 1987;83:369-70.
7. Appelboon T and Itzkowitch D. Cyclosporin in successful control of rapidly progressive scleroderma. JAMA 1986;82:886-7.
8. Knop J, Bronsman G. Cyclosporin in treatment of progressive systemic sclerosis. In: Schindler R, ed. Cyclosporin in autoimmune diseases. Berlin: Springer Verlag; 1985:199-201.
9. Zachariae M, Halkier-Sorensen L, Heickendorf L et al. Cyclosporin A treatment of systemic sclerosis. Br J Dermatology 1990;122:677-81.
10. Frances C, Brauclet MC, Bletry O et al. Skin collagen from scleroderma patients before and after cyclosporin A treatment. Clin Exp Dermatol 1988;13:1-31.
11. Masashi Oni, Hatamochi A, Arakawa M, Ueki H. Effects of cyclosporin A on cell proliferation and collagen production by human skin fibroblasts. J Dermatol Sci 1991,2:274-80.
12. Scoble JE, Freestone A, Vargheri Z et al. Cyclosporin induced renal magnesium leak in renal transplant patients. Nephrol Dialysis, Transplant 1990;5:812-15.
13. Sibley RK, Rynariewicz J, Ferguson RM et al. Morphology of cyclosporin nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisolone. Surgery 1983;94:225.
14. Seigl H, Ryffel B, Shoemaker P et al. Cyclosporine, the renin-angiotensin-aldosterone system and renal adverse reactions. Transplant Proc 1983; 15:2719-25.
15. Scherrer U, Vissing S et al. Cyclosporine induced sympathectic activation and hypertension after heart transplantation. New Engl J Med 1990;323:693-8.
16. Sweny P, Liu SF, Scoble JE et al. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study. Transplant Int 1990;3:19-22.
17. Bryan, Myers D, Ross J et al. Cyclosporine associated chronic nephropathy. New Engl J Med 1984;311: 699-705.
18. Grace A, Barradas MA, Mikhailidis DP et al. Cyclosporin A enhancer platelet aggregation. Kidney Int 1987;32:889-95.
19. Leithner C, Sinzinger H, Pohanka, E et al. Recurrence of haemolytic-uraemic syndrome triggered by cyclosporin A after renal transplantation. Lancet 1982;i: 1470.
20. Zachariae H, Hansen E, Steen Olsen T. Haemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A. Acta Derm Venereal 1992; 72:307-9.
21. Feutren G, Mihatsch MJ. Risk factors for cyclosporin induced nephropathy in patients with autoimmune diseases. New Engl J Med 1992;326:1654-60.
22. Clements PJ, Lachenbruch PA, Sterz M et al. Cyclosporine in systemic sclerosis. Arthritis Rheum 1993;36: 75-83.